Until mid-2018, the preferred initial antiretroviral therapy (ART) recommended in the World Health Organization (WHO) guidelines for human immunodeficiency virus type 1 (HIV-1) infection consisted of two nucleoside reverse-transcriptase inhibitors (NRTIs) combined with a nonnucleoside…